Vascular Endothelial Growth Factor in Predicting Outcome in Breast Cancer
Peter Krippl, Uwe Langsenlehner, Hellmut Samonigg, Wilfried Renner, H Köppel
Abstract
Peter Krippl, Uwe Langsenlehner, Hellmut Samonigg, Wilfried Renner, H Köppel
Abstract
To the editor: We have read with great interest the work by Konecny et al. about HER-2/neu and vascular endothelial growth factor (VEGF) expression and breast cancer outcome [(1)][1] . As we reported recently, a polymorphism downstream of the VEGF gene, 936C>T, was associated with VEGF expression
OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
To the editor: We have read with great interest the work by Konecny et al. about HER-2/neu and vascular endothelial growth factor (VEGF) expression and breast cancer outcome [(1)][1] . As we reported recently, a polymorphism downstream of the VEGF gene, 936C>T, was associated with VEGF expression
Key concepts: Breast cancer, Medicine, Vascular endothelial growth factor, Cancer, Oncology, Internal medicine, VEGF receptors